| S4211 |
Montelukast Sodium
|
Montelukast Sodium selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Solutions are unstable and should be fresh-prepared.
|
-
Sci Rep, 2025, 15(1):12720
-
Biochem Biophys Res Commun, 2022, 594:31-37
-
Cancer Immunol Immunother, 2021, 70(1):203-213
|
|
| S1633 |
Zafirlukast
|
Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.
|
-
Int J Immunopathol Pharmacol, 2025, 39:3946320251351083
-
Sci Rep, 2023, 13(1):13239
-
Sci Rep, 2023, 13(1):13239
|
|
| S5783 |
Montelukast
|
Montelukast(MK0476) is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
|
-
Eur J Pharmacol, 2024, 985:177058
-
Biochem Biophys Res Commun, 2022, 594:31-37
-
Cancer Immunol Immunother, 2021, 70(1):203-213
|
|
| S0505 |
MK-571 sodium salt
|
MK-571 sodium salt (L-660711) is a selective, orally active antagonist of leukotriene D4 receptor. It is also an inhibitor of multidrug resistance-associated protein MRP4 (ABCC4) and ABCC1 (MRP1).
|
-
Diagnostics -Basel), 2023, 13(16)2646
-
Diagnostics (Basel), 2023, 13(16)2646
-
Cancers (Basel), 2022, 14(11)2643
|
|
| S0428 |
Etalocib
|
Etalocib(LY293111, VML295) is a leukotriene B4 receptor (LTB4R) antagonist that blocks activation of human neutrophils.
|
|
|
| S2959 |
LY255283
|
LY255283 is an antagonist of leukotriene B4 (LTB4) receptor (BLT2) that displaces [3H]LTB4 from its binding site on lung membranes with pKi of 7.0.
|
-
J Transl Med, 2023, 21(1):923
|
|
| S8126 |
MK-571 (L-660711)
|
MK571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.
|
-
Nat Commun, 2025, 16(1):6942
-
STAR Protoc, 2025, 6(2):103777
-
Cancers (Basel), 2023, 15(15)3774
|
|
| S3998 |
(+)-α-Lipoic acid
|
(+)-α-Lipoic acid ((R)-(+)-α-Lipoic acid, α-Lipoic acid, Alpha-Lipoic acid), a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. This compound is an essential cofactor of mitochondrial enzyme complexes. This chemical inhibits NF-κB-dependent HIV-1 LTR activation.
|
-
J Clin Invest, 2024, 134(22)e181314
|
|
| E2671 |
SR 2640 hydrochloride
|
SR2640 hydrochloride is a potent and selective competitive leukotriene D4/E4 antagonist.
|
|
|